Heit JA - Search Results

1

Low-molecular-weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement.

Heit JA. Heit JA. Thromb Res. 2001 Jan 1;101(1):V163-73. doi: 10.1016/s0049-3848(00)00388-1. Thromb Res. 2001. PMID: 11342096 Review.

2

Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.

Heit JA, Berkowitz SD, Bona R, Cabanas V, Corson JD, Elliott CG, Lyons R. Heit JA, et al. Thromb Haemost. 1997 Jan;77(1):32-8. Thromb Haemost. 1997. PMID: 9031445 Clinical Trial.

3

Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.

Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J. Heit JA, et al. Ann Intern Med. 2000 Jun 6;132(11):853-61. doi: 10.7326/0003-4819-132-11-200006060-00002. Ann Intern Med. 2000. PMID: 10836911 Clinical Trial.

4

The epidemiology of venous thromboembolism in the community.

Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O'Fallon WM, Melton LJ 3rd. Heit JA, et al. Thromb Haemost. 2001 Jul;86(1):452-63. Thromb Haemost. 2001. PMID: 11487036

5

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group. Heit JA, et al. Arch Intern Med. 2001 Oct 8;161(18):2215-21. doi: 10.1001/archinte.161.18.2215. Arch Intern Med. 2001. PMID: 11575978 Clinical Trial.

6

Prevention of venous thromboembolism.

Heit JA. Heit JA. Clin Geriatr Med. 2001 Feb;17(1):71-92. doi: 10.1016/s0749-0690(05)70107-5. Clin Geriatr Med. 2001. PMID: 11270135 Review.

7

The epidemiology of venous thromboembolism.

Heit JA, Spencer FA, White RH. Heit JA, et al. J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6. J Thromb Thrombolysis. 2016. PMID: 26780736 Free PMC article. Review.

8

Mapping out the future in venous thromboembolism and acute coronary syndromes.

Heit JA. Heit JA. Semin Thromb Hemost. 2002 Aug;28 Suppl 3:33-9. doi: 10.1055/s-2002-34073. Semin Thromb Hemost. 2002. PMID: 12232821 Review.

9

The epidemiology of venous thromboembolism in the community: implications for prevention and management.

Heit JA. Heit JA. J Thromb Thrombolysis. 2006 Feb;21(1):23-9. doi: 10.1007/s11239-006-5572-y. J Thromb Thrombolysis. 2006. PMID: 16475038 Review.

10

Risk factors for venous thromboembolism.

Heit JA. Heit JA. Clin Chest Med. 2003 Mar;24(1):1-12. doi: 10.1016/s0272-5231(02)00077-1. Clin Chest Med. 2003. PMID: 12685052 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters